NKG2D-IN-1
NKG2D-IN-1 (compound 21) is a natural killer group 2D receptor (NKG2D) inhibitor with IC50s of 0.3 µM and 0.7 µM in NKG2D/MICA and ULBP6 TR-FRET assays, respectively[1].
Product Specifications
UNSPSC
12352005
Target
C-type Lectin-like Receptors (CTLRs)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nkg2d-in-1.html
Purity
99.84
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN1N=CC=C1C2=CC(C(NC(C(N(C)C)=O)C3=CC=CC(C(F)(F)F)=C3)=O)=C(C4=CC=C(C(F)(F)F)C=C4)C=C2
Molecular Formula
C29H24F6N4O2
Molecular Weight
574.52
References & Citations
[1]Jocelyn Wang, et al. Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D) . Bioorg Med Chem Lett. 2023 Sep 29:129492.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6189086-01 0.1 mL
BLM (Bloom Syndrome Protein, RecQ Protein-like 3, DNA Helicase, RecQ-like Type 2, RECQL3, RECQ2) (MaxLight 405)
Ask
View Details 
MBS6189086-02 5x 0.1 mL
BLM (Bloom Syndrome Protein, RecQ Protein-like 3, DNA Helicase, RecQ-like Type 2, RECQL3, RECQ2) (MaxLight 405)
Ask
View Details GTR15383883 1 Vial
Lentiviral human TCL1A sgRNA gene knockout kit - Lentiviral human TCL1A sgRNA gene knockout kit (25)
Ask
View Details 
036961-PE 200 µL
IKKB, phosphorylated (S697) (IKBKB, IKKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta) (PE) discontinued
Ask
View Details